CDC Website CDC Website

To Join the NPIN community or

You are here

Injecting Drug Users/Needle Sharing Partners

Form Display: 

Organization-AdminForm

HIV and Substance Abuse in the United States

Edith Jickling's picture
This fact sheet summarizes the link between HIV and substance abuse in the U.S. The report then summarizes the most commonly used substances and HIV risk, as well prevention challenges and how CDC is enhancing its prevention methods.

Getting PrEPPED

Edith Jickling's picture
This infographic provides details that may be useful for individuals facing problems with insurance covering the costs of Truvada for PrEP.

HIV and Injection Drug Use Syringe Services Programs for HIV Prevention

Edith Jickling's picture
This Vital Signs highlights the importance of expanding access to SSPs, which provide sterile needles and syringes and ideally offer many other comprehensive services to help improve the health of PWID and their communities, such as treatment for substance use disorder, HIV, and hepatitis testing and linkage to treatment, and safe disposal of used syringes.

Urgent Response Needed to Nation's Hepatitis C Epidemic

The Call to Action proposes a set of recommendations to prevent new infections; reduce deaths and adverse health outcomes; address disparities; coordinate action among federal, state, and local agencies and health systems; and ultimately reduce health care costs.

PrEP for HIV Prevention among Substance Using Populations (R01 Clinical Trial Optional)

NIDA is interested in research that addressing research gaps related to PrEP and its use among substance users, with the goals of improving PrEP management and implementation. Current US Public Health Service PrEP guidelines recommend PrEP for people who inject drugs (PWID) and mention alcohol and illicit drug use as potential concerns for clinical management. Only one clinical trial has evaluated PrEP among PWID and systematic data regarding the broader use of PrEP among substance users are limited.

PrEP for HIV Prevention among Substance Using Populations (R01 Clinical Trial Optional)

Edith Jickling's picture

NIDA is interested in research that addressing research gaps related to PrEP and its use among substance users, with the goals of improving PrEP management and implementation. Current US Public Health Service PrEP guidelines recommend PrEP for people who inject drugs (PWID) and mention alcohol and illicit drug use as potential concerns for clinical management. Only one clinical trial has evaluated PrEP among PWID and systematic data regarding the broader use of PrEP among substance users are limited.

National Harm Reduction Technical Assistance and Syringe Services Program (SSP) Monitoring and Evaluation Funding Opportunity

This three year program will strengthen the capacity and improve the performance of harm reduction programs throughout the United States; and implement a monitoring and evaluation of syringe services programs. The purpose of this project is to strengthen harm reduction programs in order to prevent infectious disease resulting from injection drug use, and improve health outcomes for people who inject drugs, including strengthening linkage to medication-assisted treatment.

Pages

Subscribe to RSS - Injecting Drug Users/Needle Sharing Partners